(Q37065133)

18 August 2017

1 reference

title

Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema (English)

1 reference

18 August 2017

Michael M Frank

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

Annals of Allergy, Asthma & Immunology

18 August 2017

published in

1 reference

18 August 2017

volume

100

1 reference

18 August 2017

issue

1 Suppl 2

1 reference

18 August 2017

page(s)

S23-9

1 reference

Hereditary angioedema: the clinical syndrome and its management in the United States

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Autoantibody-mediated acquired deficiency of C1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Hereditary angioedema: new findings concerning symptoms, affected organs, and course

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Hereditary angioneurotic edema. Clinical aspects and extended diagnostic and therapeutic possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

DX-88 and HAE: a developmental perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960583-2

7 January 2021

10.1016/S1081-1206(10)60583-2

Identifiers

DOI

1 reference

18 August 2017

1 reference